Concepedia

Bryan J. Witherbee

BJ

Statistics

Publications

8

Citations

752

H-Index

8

Active since

2000

Affiliations

Pfizer (United States)(Current)

University of Missouri–St. Louis

Bryan J. Witherbee is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2000–2003

8

Publications

8

Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B

Thompson N. Doman, Susan L. McGovern, Bryan J. Witherbee et al. · Journal of Medicinal Chemistry · 2002 · 467 citations · Full text

, , +17

Activation of the Hexosamine Signaling Pathway in Adipose Tissue Results in Decreased Serum Adiponectin and Skeletal Muscle Insulin Resistance

Mark Hazel, Robert C. Cooksey, Deborah L. Jones et al. · Endocrinology · 2003 · 73 citations

, , +17

Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein

Mark A. Massa, Dale Spangler, Richard C. Durley et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 56 citations · Full text

, , +13

Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein

Emily J. Reinhard, Jane L. Wang, Richard C. Durley et al. · Journal of Medicinal Chemistry · 2003 · 49 citations · Full text

, , +13

Discovery of Chiral <i>N</i>,<i>N</i>-Disubstituted Trifluoro-3-amino-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein

Richard C. Durley, Margaret L. Grapperhaus, Mark A. Massa et al. · Journal of Medicinal Chemistry · 2000 · 31 citations · Full text

, , +6

1–5 of 8